iPhone Device Helps Diabetics Monitor Condition


A new device that allows Diabetics to manage their condition using their iPhone has gone on sale.

iBGStar Diabetes Monitor

The iBGStar glucose monitor attaches to an iPhone or iPod Touch, and allows blood sugar levels to be checked at any time.

The iBGStar device is developed by Sanofi Aventis, and is being rolled out across Boots stores in the UK, at an estimated retail price of £48. The device comes inclusive with a free diabetes app manager, making it possible to track and analyse medical data. Additional support is available to users of the device, via a 24-hour freephone helpline, plus a website, patient support material, lifetime meter replacement service and free control solution.

Diabetes affects almost 3 million people in the UK, and accurate monitoring of blood sugar levels is vital in helping suffers live with the disease. This is particularly important for sufferers of type-1 diabetes. High blood sugar can leave Diabetics at risk of complications leading to damage to kidneys, the heart, nerves and the eyes.

The iBGStar device works in a similar manner to traditional blood glucose monitors, by analysing the sugar levels in a drop of blood. The data is flashed on the screen of the phone, showing users the current status of their blood sugar. The device is already on sale in other European countries, and sales have so far been encouraging.

TV personality Dom Littlewood, himself a sufferer of Diabetes from his teens, was on hand to promote the launch of the device. “I lead a hectic lifestyle and so keeping an eye on my blood glucose levels is challenging,” he said. “iBGStar gives me the reassurance of knowing that I can get accurate blood glucose results using my iPhone, which I carry around anyway.”

Sarah Johnson, from Diabetes research charity JDRF, said: “Good blood glucose control is vital to reducing the long-term effects of diabetes, but it can be difficult and demanding to achieve. As such, we welcome all developments in technology that can help people with type-1 and type-2 diabetes take control of their condition.”